Printer Friendly
The Free Library
14,557,847 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Articles from Transplant News (September 13, 2002)

1-18 out of 18 article(s)
Title Author Type Words
All-in-one CT protocol improves evaluation of potential living liver donors. Brief Article 165
CryoLife reaches agreement with FDA, which allows distribution of tissue deemed medically urgent. Brief Article 337
Excerpt from Organ Donation: Time has come for study of incentives - Editorial, August 19, 2002, American Medical News. Brief Article 275
Failure to differentiate into types of tissues raises questions over utility of adult stem cells, new study finds. Correspondent, Michele Grygotis Transplant News Special Brief Article 439
Fifth patient to receive artificial heart implant dies; Christerson nears 1-year anniversary. Brief Article 270
First patients receive islet transplants in Northwest. Brief Article 127
Government orders OPOs, transplant centers to be on alert for West Nile Virus after 4 recipients contract illness. Brief Article 430
Hyperlipidemia in relatives predicts abnormal lipid profile after kidney transplant. Brief Article 91
Implantable heart pumps reversed end-stage heart failure in 10 patients, surgeon reports. Brief Article 145
In utero transplant of fetal liver cells reconstitutes T, NK cells in male fetus with SCID. Brief Article 101
Intel chairman gives UCSF $5 million matching grant for stem cell studies. Brief Article 194
Mt. Sinai's troubles continue; health department levies big fine, suspends living liver donor program indefinitely. Brief Article 679
New drugs, novel therapies to triple pharmaceutical revenues by 2008-Frost & Sullivan. Brief Article 162
New livers for couple poisoned by mushrooms. 136
Position of the Transplantation Society on Paid Organ Donation. Brief Article 542
Safe to travel after heart transplant. Brief Article 182
Time for Transplantation Society to change position on paid organ donation, ethics committee member says. Publisher, Jim Warren Editor & Brief Article 837
VistaGen Therapeutics awarded $1.7 million NIH Phase 2 SBIR grant to develop predictive assays. Brief Article 149

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles